International Clinical Trial: Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07308834) titled 'Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis' on Dec. 22, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: CarthroniX, Inc.

Condition: Osteoarthritis of the Knees

Intervention: Drug: CX-011

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: February 1, 2026

Target Sample Size: 72

To know more, visit https://clinicaltrials.gov/study/NC...